Thursday, May 26, 2016
As reported in this local article, "Ohio is poised to become the 25th state to legalize medical marijuana after state lawmakers approved a fast-moving bill Wednesday evening in a close vote." Here are more of the details and the enduring issues about marijuana reform still in play in the Buckeye State:
As I explained in this prior post, I think the final complicated structure for medical marijuana reform enacted by the Ohio legislature may prove to have even more benefits for lawyers and lobbyists than for prospective patients. But I suppose time will tell on this front, and how MPP (and advocates and polls) respond to bill may ultimately script the future of marijuana reform in the state more than the particulars of this legislation.
The bill cleared the Ohio Senate on Wednesday in a bipartisan 18-15 vote. The House later agreed to the changes, sending the bill to Gov. John Kasich. Kasich has said he would support a medical marijuana bill if doctors led on the issue.
The vote caps a historic debate at the Statehouse about medical marijuana, a subject the conservative legislature has been reluctant to take up for years. But last year's failed recreational marijuana measure, sky-high support for medical marijuana in public opinion polls and the prospect of another ballot initiative nudged lawmakers to act....
People with one of about two dozen qualifying medical conditions could use marijuana if recommended by their physician. Patients could not smoke or grow their own marijuana, but vaping would be allowed.
Oils, tinctures, patches and plant material would be sold in dispensaries licensed by the Ohio State Board of Pharmacy. The Department of Commerce would write rules for licensing cultivators, processors and testing labs. The State Medical Board would register physicians and determine education requirements for those physicians. A bipartisan 13-member Medical Marijuana Advisory Board would recommend rules to the three regulatory agencies.
The program would have to be up and running within two years. Patients and caregivers would have an "affirmative defense" from arrest or prosecution if caught with marijuana before it's legally sold in Ohio, as long as use was recommended by a physician and meets the criteria established for the program.
Medical marijuana patients could be fired for violating an employer's drug-free workplace policy, as they are in other medical marijuana states. Patients would then be ineligible for unemployment benefits.
Sen. Kenny Yuko, a Richmond Heights Democrat and long-time medical marijuana supporter, shared the stories of several Ohioans who told lawmakers they or their children would benefit from marijuana. Marijuana has been proven to reduce seizures, pain and, Yuko said while showing pictures of would-be patients. "This bill is not perfect, folks, but it's what Ohio patients need," Yuko said. "If we can give one veteran comfort, if we can ease one patient's horrible pain, if we can prevent one heroin overdose or save one child's life -- this bill will be worth it."
Senators differed in their reasons for voting no. Some opposed marijuana use or said the federal Food and Drug Administration should approve marijuana for medicinal use. Sen. Jay Hottinger, a Newark Republican, said law enforcement and anti-drug activists in his district urged him to oppose the bill. "What we have before us today is not simply a child suffering seizure from epilepsy but something much greater than that," Hottinger said.
Others disagreed with language that allowed patients to be fired for their marijuana use and unable to collect unemployment compensation. Sen. Sandra Williams, a Cleveland Democrat, voted against the bill because she thought the issue should be decided by voters in November.
Nicole Scholten, a Cincinnati mom whose daughter suffers from seizures and cerebral palsy, was among the dozens of medical marijuana supporters watching the Senate vote Wednesday night. Scholten, who has been trying to convince lawmakers to act for years, said she felt conflicted about the vote. "We are on the way to being a state that supports patients that are not being helped by FDA-approved medications," Scholten said.
The bill would cover her daughter, Scholten said, but there are several conditions the bill doesn't cover. And she said nurse practitioners and other medical professions who prescribe controlled substances should also be allowed to recommend medical marijuana, as they are in the proposed ballot measure.
Meanwhile, Ohioans for Medical Marijuana plans to continue collecting the 305,591 signatures of Ohio voters needed by July 6 to put its medical marijuana measure on the November ballot. The group is backed by national organization Marijuana Policy Project. Their proposed constitutional amendment would allow smoking in private areas and home grow and includes more qualifying medical conditions including severe nausea and autism.
Campaign spokesman Aaron Marshall said House Bill 523 is a step forward but still too restrictive. "Our Constitutional amendment builds on the legislature's work by incorporating national best practices and offers voters an opportunity to enact a law free of the horse-trading inherent in the legislative process," Marshall said.
After the bill is sent to Kasich, he has 10 days to sign it. If he doesn't sign, it automatically becomes law. The law is effective 90 days after Kasich signs, likely sometime in early September.
Tuesday, May 24, 2016
GOP Congressman Dana Rohrabacher admits currently using topical marijuana to treat his arthritis pain
The Huffington Post has this notable new article headlined "GOP Congressman Says He Uses Medical Marijuana To Ease Arthritis Pain: The plant helps relieve pain so severe it was waking him up at night." Here are the details:
Rep. Dana Rohrabacher (R-Calif.), a leading voice for the reform of marijuana laws in the United States, became the first sitting member of Congress in recent history to admit to medical marijuana use.
Rohrabacher, speaking to a group of cannabis activists on Tuesday on Capital Hill, said he has been an avid surfer for about three decades but had not been able to enjoy the sport for about a year and a half due to arthritis pain he’s developed in his shoulder. The pain became so severe that it has disrupted his sleep, the lawmaker said. That is, until he tried medical marijuana.
“I went to one of these hempfests or something like that they had in San Bernardino,” Rohrabacher said, as first reported by Russ Belville at Cannabis Radio.
At the hemp festival, he met a vendor who introduced him to a cannabis-infused topical rub. “This guy was showing me the medical things and all that, and he says, ‘You should try this.’ And it’s a candle and you light the candle, and the wax is in there and it melts down, and then you rub it on whatever you’ve got problems with,” the Republican congressman said.
He finally tried the product a couple of weeks ago, and that was “the first time in a year and a half that I had a decent night’s sleep because the arthritis pain is gone.” The attendees cheered his comments.
Rohrabacher, a vocal supporter for reform of the nation’s marijuana laws, is one of the main sponsors of a measure that blocked the Department of Justice from using funds to target and prosecute medical marijuana patients or businesses who are operating legal in their state. The amendment has been reauthorized for the past two fiscal years.
“Now don’t tell anybody I broke the law, they’ll bust down my door and take whatever’s inside and use it as evidence against me, whatever it is,” Rohrabacher said. “The bottom line is, there’s definitely cannabis in there and it makes sure that I can sleep now.”
This was the first time Rohrabacher has spoken publicly about using medical cannabis, his press secretary Ken Grubbs told The Huffington Post. It was also the first time in recent history that a sitting congressman admitted to using medical marijuana, said Marijuana Majority founder Tom Angell.
“Putting a face on the people who use marijuana will help immensely in the battle to end criminalization and other forms of harmful discrimination,” Angell added. “It’s now going to be much harder for members of Congress, particularly those in the GOP caucus, to vote against medical marijuana, since they now know that one of their friends and colleagues is directly benefiting from it.”
"As more states legalize marijuana, adolescents' problems with pot decline: Fewer adolescents also report using marijuana"
The title of this post is the headline of this notable Science Daily release that reports on this notable newly published research in the Journal of the American Academy of Child & Adolescent Psychiatry that surely should be getting lots and lots of attention from marijuana reform advocates. Here are the basics via the Science Daily:
A survey of more than 216,000 adolescents from all 50 states indicates the number of teens with marijuana-related problems is declining. Similarly, the rates of marijuana use by young people are falling despite the fact more U.S. states are legalizing or decriminalizing marijuana use and the number of adults using the drug has increased.
Researchers at Washington University School of Medicine in St. Louis examined data on drug use collected from young people, ages 12 to 17, over a 12-year span. They found that the number of adolescents who had problems related to marijuana -- such as becoming dependent on the drug or having trouble in school and in relationships -- declined by 24 percent from 2002 to 2013.
Over the same period, kids, when asked whether they had used pot in the previous 12 months, reported fewer instances of marijuana use in 2013 than their peers had reported in 2002. In all, the rate fell by 10 percent. Those drops were accompanied by reductions in behavioral problems, including fighting, property crimes and selling drugs. The researchers found that the two trends are connected. As kids became less likely to engage in problem behaviors, they also became less likely to have problems with marijuana.
The study's first author, Richard A. Grucza, PhD, an associate professor of psychiatry, explained that those behavioral problems often are signs of childhood psychiatric disorders. "We were surprised to see substantial declines in marijuana use and abuse," he said. "We don't know how legalization is affecting young marijuana users, but it could be that many kids with behavioral problems are more likely to get treatment earlier in childhood, making them less likely to turn to pot during adolescence. But whatever is happening with these behavioral issues, it seems to be outweighing any effects of marijuana decriminalization."
The new study is published in the June issue of the Journal of the American Academy of Child & Adolescent Psychiatry. The data was gathered as part of a confidential, computerized study called the National Survey on Drug Use and Health. It surveys young people from different racial, ethnic and income groups in all 50 states about their drug use, abuse and dependence.
In 2002, just over 16 percent of those 12 to 17 reported using marijuana during the previous year. That number fell to below 14 percent by 2013. Meanwhile, the percentage of young people with marijuana-use disorders declined from around 4 percent to about 3 percent.
At the same time, the number of kids in the study who reported having serious behavior problems -- such as getting into fights, shoplifting, bringing weapons to school or selling drugs -- also declined over the 12-year study period. "Other research shows that psychiatric disorders earlier in childhood are strong predictors of marijuana use later on," Grucza said. "So it's likely that if these disruptive behaviors are recognized earlier in life, we may be able to deliver therapies that will help prevent marijuana problems -- and possibly problems with alcohol and other drugs, too."
Lobbyists, start your engines: revisions to Ohio medical marijuana bill creates array of regulators and rule-makers
As reported in this local article, headlined "Senators remove pharmacist requirement from medical marijuana bill," the Ohio General Assembly has done some additional notable tweaking of the medical marijuana legislation being fast-tracked in this state. Here are the latest details, along with my explanation for the Indy 500-inspired title to this post:
Senators vetting a medical marijuana bill eliminated a requirement that every marijuana dispensary be run by a licensed pharmacist, expanded the definition of pain to qualify for medical marijuana and other changes cheered by medical marijuana advocates.
The Senate Government Oversight and Reform Committee added the pharmacist requirement last week as well as put the program under the oversight of the Ohio State Board of Pharmacy. The Ohio Pharmacists Association supported the change, but patient advocates said would increase patient costs and render Ohio's medical marijuana program ineffective.
The committee is expected to make small changes to the bill Wednesday morning before approving it for a full floor vote as early as Wednesday afternoon. The revised bill then would need approval from the House before heading to Gov. John Kasich's desk....
Three states require pharmacists in medical marijuana dispensaries: Connecticut, Minnesota and New York. Advocates have criticized those states for having overly restrictive programs. Sen. Dave Burke, a Marysville Republican and pharmacist, said the pharmacist requirement raised concerns about patient access, and the bill has other safeguards to ensure products are safely administered. "We're not wanting to be restrictive, we're not wanting to be burdensome but we don't want to expose people to harm," Burke said.
House Bill 523 would allow patients with about two dozen qualifying conditions to buy and use marijuana if recommended by a licensed Ohio physician. The Ohio Department of Commerce would write the rules and regulations for who could commercially grow or manufacture products from marijuana. Smoking and home growing are not allowed in the bill. Patients would have an affirmative defense from arrest and prosecution to possess and use marijuana before dispensaries are up and running.
Patients would have to have a doctor's recommendation and the marijuana would have to be legal under the Ohio law. Burke said the pharmacy board will also draft rules allowing patients from states with similar requirements to access Ohio medical marijuana. "It has to fit in the framework -- you can't just bring your baggie of Colorado weed to Ohio," Burke said....
Lawmakers supporting the bill are motivated in part by a constitutional amendment planned for the November ballot. Ohioans for Medical Marijuana spokesman Aaron Marshall said the revised bill still does not address patient concerns and is inferior to his group's proposed measure. The amendment allows patients to smoke marijuana and grow their own or enlist a caregiver to grow for them. Marijuana won't be covered by medical insurance plans, Marshall said, so home grow is the best way to ensure poor Ohioans will have access to the plant.
Changes made Tuesday morning:
- Chronic and severe pain is one qualifying condition and intractable pain is a separate condition.
- The pharmacy board would license retail dispensaries, register patients and regulate marijuana packaging and acceptable paraphernalia.
- The Department of Commerce would license cultivators, processors and testing labs and operate a seed-to-sale tracking system. Cultivator licensing rules would have to be written within 240 days of the bill's effective date instead of 180 days.
- The state medical board would certify physicians for the program.
The title of this post is my basic reaction to the reality that, in this latest version of Ohio's medical marijuana bill, there will be at least three enduring regulatory bodies in charge of various parts the state's marijuana programming: the Department of Commerce, the board of pharmacy, and the state medical board. In addition, the bill also creates for, a five-year period, a multi-member "medical marijuana advisory committee" which "may develop and submit to the department of commerce, state board of pharmacy, and the state medical board any recommendations related to the medical marijuana control program." So, any patient or parent or doctor or caregiver or cultivator or processor or lab or any other business or person wanting to influence Ohio's regulatory structures for medical marijuana will want/need to consider lobbying various regulatory bodies and the medical marijuana advisory committee.
And, of course, because all these structures are being created through standard state legislation, the many diverse regulatory bodies are not the only ones to be lobbied. I would expect in the years ahead, both pro- and anti-marijuana advocates and their lobbyists will sometimes go over the heads of the assigned regulators to try to get the General Assembly through future legislation to place new/changed marijuana rules directly into Ohio's Revised Code.
Long story short: though I am not yet sure that the regulatory structure being created now in Ohio will facilitate a robust medical marijuana industry, I am sure that there is likely going to have to be a robust medical marijuana lobby industry in the Buckeye State at least for the next few years.
The title of this post is the title of this new report produced by Gargen State public policy groups. This ACLU of New Jersey press release, which is subtitled "NJ Policy Perspective & NJ United for Marijuana Reform analysis projects $300 million in annual sales tax revenue to come with legalization for adults," provides this context and highlights:
New Jersey would bring in hundreds of millions of dollars in new revenue by legalizing marijuana, a new report released by New Jersey Policy Perspective and New Jersey United for Marijuana Reform has found. Legalization, taxation, and regulation of marijuana for use by adults aged 21 and older would ultimately add an estimated $300 million in sales tax to state coffers rather than divert consumers to the illegal market, the two policy-focused groups said at a Trenton press conference.
"The lessons from around the country are loud and clear: marijuana legalization makes fiscal sense, and it makes practical sense," said New Jersey Policy Perspective Policy Analyst Brandon McKoy, a co-author of the report. "Expanding economic opportunities and addressing our persistent budget deficit aren't the only reasons to legalize and regulate marijuana, but they are extremely persuasive ones."
The report estimates that New Jersey would bring in at least $300 million annually if marijuana legalization were fully implemented, using graduated tax increases over a three-year period, going from 5 percent, to 15 percent, to the final rate of 25 percent. The first-of-its-kind report in New Jersey relies on conservative estimates, predicting the tax revenue only from marijuana sales. The report's projections are based on the experiences of other states, current information on marijuana users in New Jersey and the surrounding area, current pricing, and the tax structure of other states as they relate to New Jersey's interests.
Including a small percentage of New Yorkers and Pennsylvanians from counties neighboring New Jersey who are expected to participate in the legal, regulated market, the state could take in approximately $305.4 million once the sales tax is fully scaled to 25 percent, the report said. The report estimates that approximately 343,100 New Jerseyans would participate in a legal marketplace, spending $1.2 billion each year. Currently, New Jerseyans spend more than $850 million on marijuana each year. The calculation of tax revenue was based on a price of $350 per ounce, similar to the current estimated price of $343 per ounce in New Jersey.
Legalization would bring other economic benefits not covered in the report, such as job creation, growth in business, research and development, and boosts in property, agricultural, business, and income taxes. In addition, it would increase public safety, protect young people, save resources, advance racial justice, bolster public health, and reduce the strain on the police, corrections, and the criminal justice system, the report argues. New Jersey arrests more people for marijuana possession each year than for any other crime. A June 2015 Rutgers-Eagleton poll found that 58 percent of New Jerseyans support legalizing, taxing and regulating marijuana for use by adults aged 21 and older.
Sunday, May 22, 2016
Could Michigan be among the states voting on legalizing marijuana for recreational use in November 2016?
In looking at this fall's election as a huge one for the future of marijuana law, I have had my eye on five states in which it seemed very likely voters would be considering recreational reforms via ballot initiative: Arizona, California, Maine, Massachusetts and Nevada. But this local article, headlined "Marijuana advocates rally at Michigan Capitol in final push for petition signatures," suggests that there is a chance Michigan voters also might get an opportunity to speak directly on this issue come November. Here are the basic details:
Supporters of a ballot drive to legalize recreational marijuana use in Michigan lined the Capitol lawn Friday afternoon in a final effort to round up signatures and denounce recent legislative efforts to change state signature gathering law. Jeffrey Hank chairs MILegalize, the group behind the ballot drive. Prior to the rally, he said the group had collected a total 315,000 signatures, which had not yet been vetted.
The purpose of the rally was to bring in any outstanding petition sheets and make one final push for signatures before the June 1 deadline in the same place the drive began last June, Hank added. The group needs at least 252,523 valid signatures to get on the November 2016 statewide ballot, which would put the question of whether recreational use, purchase and possession of marijuana for people over 21 in Michigan should be legal before voters.
One notable speaker at the rally was Rep. Jeff Irwin, D-Ann Arbor, who recently introduced legislation that would decriminalize marijuana in Michigan and has long advocated for reforms to marijuana law. He told rally attendees that in all of his experience gathering signatures for various ballot issues, he's never worked on an issue like marijuana legalization, because most people know exactly how they feel about the issue one way or the other. "Most people are grabbing it out of your hands — they want to sign, they want to move this issue forward," Irwin said. "It strikes right to the heart of how people feel about government and what they want their government doing."
Irwin said, to cheers from the crowd, that he would prefer the government paved roads and adequately funded schools instead of wasting time and money prosecuting Michigan citizens for cannabis....
Addressing rally attendees, Hank said this is the closest a statewide recreational legalization attempt has come to succeeding in Michigan. He said the legislature's efforts to change the law [about signature gathering] at this stage merely showed lawmakers were scared of how far they'd come. "If we get this close and we fail, we will have missed a historic opportunity," Hank told the crowd.
I know that in Ohio it is not uncommon for at least 25% and sometimes as many as 50% of collected signatures in support of a ballot initiative to eventually be deemed invalid. So this article's reporting on the signature gathering leads me to think it is still not likely a recreational reform initiative will make it to Michigan voters this year. Still, especially given that Michigan was the first rust-belt state to enact significant medical marijuana reforms via ballot initiative, this state is still one worth wathcing closely in the months (and years) ahead.
Saturday, May 21, 2016
Notable commentary highlights how "Legalized Pot, Free Trade" could significantly improve US-Mexico interactions
This notable new New York Times commentary, authored by Ioan Grillomay and headlined "Legalized Pot, Free Trade," highlights some international benefits that could and should flow from modenr marijuana reform efforts. Here are excerpts:
Speaking last month at the United Nations special session on drugs, President Enrique Peña Nieto said he wanted to relax the nation’s marijuana laws. He has since sent Mexico’s Congress a bill to legalize medicine that contains cannabis, allow people to carry an ounce of marijuana without being prosecuted, and free some prisoners convicted on marijuana charges. “We Mexicans know all too well the range and the defects of prohibitionist and punitive policies, and of the so-called war on drugs that has prevailed for 40 years,” he said.
Mr. Peña Nieto is new to the drug-reform game. Only last year, he said he was against legalizing marijuana, and at one point said he was not even going to attend the United Nations session.
What happened? He seems to have realized (or been advised) that it is better to be on the side of inevitable change. The proposal follows the rapid loosening of drug laws in the United States: Four states and the District of Columbia have legalized medical and recreational marijuana, and 20 more states now permit it as medicine. The president’s shift also follows a November ruling by Mexico’s Supreme Court, which held that the government had no constitutional right to arrest people for their “civil right” of growing cannabis.
And more is coming soon. In November, Californians could vote on an initiative to legalize marijuana. If America’s richest state, and one on the border, votes yes, it will have a huge impact on Mexico. Why would the Mexican government want to crack down on traffickers taking marijuana into California if it were fully legal there?
Various Mexican politicians and activists have come out in favor of wider marijuana legalization. Among them, the opposition senator Mario Delgado has proposed the decriminalization and regulation of cultivation, production and sales across Mexico. The former president Vicente Fox also supports this idea. Mr. Peña Nieto’s proposals make sense, but there’s even more to be done. The current bill would effectively allow cannabis consumption, but it would leave most of the production and selling of it to the black market — which means largely in the hands of drug cartels.
Marijuana reform in the United States has already eaten into the business of Mexican cartels. In 2011, the year before Colorado and Washington State legalized it, the United States border patrol seized 2.5 million pounds of cannabis coming from Mexico. Last year, with marijuana legal in four states and the District of Columbia, that had fallen to 1.5 million pounds.
However, even the latest number indicates that a significant amount of marijuana is still being smuggled north. The profits pay the cartels’ assassins, as well as corrupt police officers and soldiers, who discard piles of bodies across Mexico. Amid these changing dynamics, it becomes more and more pointless for Mexican soldiers (underwritten by the United States, through the Merida Initiative) to keep up the ritual of burning marijuana crops. What is needed, then, is for both countries to move from the current mishmash of laws toward the inevitable conclusion: that marijuana becomes a legalized product that can be traded over borders.
The same market forces that shape the trade in liquor or tobacco will shape the trade in marijuana. Like those, it generates major profits for the formal economy. A research group predicts the legalized marijuana market in the United States will be worth more than $6 billion this year, rising to more than $20 billion by 2020. That could be a boon for the Mexican and United States economies.
A regulated marijuana market won’t suddenly end the bloodshed in Mexico. Cartels would still traffic cocaine, heroin and methamphetamines. The cartels have also diversified to kidnapping, extortion and even oil theft, crimes that can be dealt with only by markedly improved Mexican police forces. But marijuana reform will help immensely. Many in the ranks of Mexican cartels take their first step into the crime world by growing, smuggling or selling pot. That link would be cut, and legal jobs created. Mexican security forces could finally leave the marijuana issue behind to focus on real problems.
The United Nations special session on drugs was heavy on empty talk, but several positive things came out of it. One was that there is no appetite to make countries abide by the United Nations treaties that prohibit the legalization of marijuana. Another is that a range of voices across the world are calling for a new approach to drug policy. The growth of a legalized, binational marijuana market would be a step toward turning those calls into reality.
Friday, May 20, 2016
Regular readers are likely used to seeing me in this space praise the work being done by Brookings in general, and John Hudak in particular, in the arena of responsible and thoughtful discussion of marijuana law, policy and reform. This latest Brookings piece by Hudak, styled "A memo to Hillary Clinton and Donald Trump on marijuana policy," further demostrates why my praise is justified. I recommend the lengthy piece is full, and here are excerpts from how it starts and ends and the headings in between:
Eight months from today one of you will be inaugurated the 45th President of the United States. There is much to think about between now and then, but one issue with a penchant for falling between the cracks is marijuana policy. Marijuana policy is no longer just a punchline, reserved for the attention of activists. Marijuana policy will be a serious part of the next administration’s domestic policy, and it is critical that you create a strategy accordingly.
Both of you have suggested you are open to reforms or, at a minimum, to let states operate as they wish. However, a laissez-faire approach to cannabis is a dangerous stance that creates a bevy of policy problems at the federal, state and local levels. There is tremendous complexity involved in creating a uniform and consistent policy strategy. Marijuana will impact almost every corner of your administration — some obvious, some less so. To get it right — that is to make sure that your administration advances your policy goals — there are seven key steps to take.
1. When vetting possible appointees, ask them about cannabis....
2. Talk to Congress about marijuana....
3. Talk to states that passed marijuana reform....
4. Talk to cannabis businesses, patients, consumers, and activists....
5. Talk to marijuana reform opponents....
6. Talk to scientists studying (or trying to study) cannabis....
7. Think about your marijuana legacy....
The nation is changing its views on cannabis, and reform is not a flash in the pan, but a certainty in the future of American public policy. Your administration has the opportunity to initiate a sensible, safe, effective, and robust reform that reflects the policy changes in the states and a federal government ready to facilitate a working system. You can help mold the future of this policy, or you can be a bystander to history, remembered more for being a roadblock than a transformational policy champion. Ten years ago it would have been toxic to engage marijuana policy in this way, but as America changes its mind on cannabis, it may be even more toxic to stand by and do nothing about it.
May 20, 2016 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Thursday, May 19, 2016
The title of this post is the headline of this notable report authored by Tom Angell explaining a notable vote today in Congress. Here are the notable details:
The U.S. House took action to increase military veterans’ access to medical marijuana on Thursday.
By a vote of 233-189, representatives approved an amendment preventing the Department of Veterans Affairs (V.A.) from spending money to enforce a current policy that prohibits its government doctors from filling out medical marijuana recommendation forms in states where the drug is legal. The language is now attached to a bill funding the V.A. and military construction efforts through next year.
The U.S. Senate is expected to vote on its version of the legislation later on Thursday. Medical cannabis protections for veterans were added to that bill last month in bipartisan vote of 20-10 in the Senate Appropriations Committee. It is not expected that any senators will offer floor amendments to strike the marijuana provision before passage.
“One of the great concerns we have is how the two million young Americans who were sent to Iraq and Afghanistan reintegrate back into society,” Rep. Earl Blumenauer (D-OR), the House amendment’s sponsor, said in a floor debate early Thursday morning. “What I hear from veterans that I talk to is that an overwhelming number of them say that medical marijuana has helped them deal with PTSD, pain and other conditions, particularly as an alternative to opioids.”
Under current V.A. policy, military veterans have to go to separate private doctors to get medical marijuana recommendations, which can be costly and time-consuming. “Those patients who want to pursue medical marijuana have to go ahead and hire a physician out of their own pocket,” said Blumenauer. “Not dealing with the medical professional of their choice, their V.A. doctor, who knows them the best.”
But there was some reluctant disagreement on the House floor. “I understand that the country is evolving on this issue as many states, including my own, have moved forward on medical marijuana,” said Rep. Charles Dent (R-PA), whose home state just became the 24th in the U.S. with a comprehensive medical marijuana law. “As a member of this House, I’m a bit uncomfortable, however, in trying to dictate policy on marijuana without guidance from Food and Drug Administration, National Institutes of Health and other medical professionals.”
But Blumenauer took exception to that characterization. “This amendment does not dictate treatment options. It’s not interfering. It’s not superimposing anybody’s judgement about the merits of marijuana. It simply enables V.A. doctors and patients to interact with state-legal marijuana systems,” he said. “We should not be limiting the treatment options available to our veterans.”
Last year the Senate approved the Fiscal Year 2016 version of the V.A. spending bill, with similar medical cannabis protections for veterans attached, but the House narrowly defeated a move to add the amendment to its version of the legislation by a vote of 213-210. As a result, the provision was not included in the final omnibus appropriations package signed into law by President Obama in December.
Since then, momentum on medical cannabis and broader marijuana law reform issues has continued to increase. Last month, for example, Pennsylvania became the 24th state in the U.S with a comprehensive medical marijuana program. This month, both chambers of the Louisiana State Legislature and the Ohio House of Representatives approved medical cannabis bills.
The U.S. House measure also would have passed last year if two medical marijuana supporters hadn’t voted against it. Rep. John Garamendi (D-CA), admitted at the time that he misread the amendment and voted the wrong way. Another supporter, Rep. Morgan Griffith (R-VA) said he voted no because the measure didn’t go far enough in his view. With those two votes flipped, the result would have been 212-211.
The V.A. policy disallowing its doctors from recommending medical marijuana in states where it is legal actually expired on January 31 but, under the department’s procedures, the ban technically remains in effect until a new policy is enacted.
Advocates expect a new policy soon, but aren’t sure what it will say. In February 2015, a top V.A. official testified before a House committee that the department is undertaking “active discussions” about how to address the growing number of veterans who are seeking cannabis treatments.
Separately, a trio of Democratic senators submitted an additional amendment this week intended to spur medical cannabis research by the V.A. The V.A., in partnership with the National Center for Posttraumatic Stress Disorder may “conduct clinical research on the potential benefits of therapeutic use of the cannabis plant by veterans,” reads the amendment offered by Sens. Kirsten Gillibrand (NY), Cory Booker (NJ) and Barbara Boxer (CA).
The senators want the government to look into the use of cannabis “as a treatment to achieve and maintain abstinence from opioids and heroin.” The proposal directs the secretary of veterans affairs to submit a report on efforts to expand such research within 180 days. It is not yet clear if the amendment will receive a vote on the Senate floor.
Last week medical marijuana opponents succeeded in getting the House Rules Committee to kill two amendments aimed at increasing government research on medical marijuana’s possible impact on opioid abuse.
As reported in this local article, headlined "John Bel Edwards signs medical marijuana law," I think it is now proper to count Louisiana as a state that has now enacted real, functional broad medical marijuana reform. Here are the basics:
Gov. John Bel Edwards signed a landmark medical marijuana bill into law Thursday (May 19) that is expected to make medical marijuana available to patients for the first time in Louisiana history.
Edwards signed the bill during a ceremony on the fourth floor of the Capitol in front of key legislators who guided the bill to passage, First Lady Donna Edwards, and the families of children with conditions they believe can be treated with the drug. Among those present were a family from Edwards' hometown of Amite who have a son that suffers from daily seizures and would qualify for the drug.
"This is one of those bills I believe will have a positive impact on the people that need it the most," Edwards said. "The state of Louisiana should not interpose itself between doctors and patients when the doctors believe they have a patient who will benefit from medical marijuana."
Although Edwards' signature marked a significant moment for dispensing medical marijuana, it will be some time before doctors could actually recommend the drug to patients and a pharmacy could dispense it. By one estimate, it could take about 18 months, but if other states adopting medical marijuana legislation give any indication, it could take even longer.
Even so, advocates have said the legislation passed this session gives them hope that one day, family members could benefit from the drug and they won't have to make plans to move to states like Colorado where medical marijuana is available. Edwards said the idea that families would move away from Louisiana to obtain a safe and legal product in other states was a driving force behind his support.
"It simply is unacceptable to tell parents of kids that if they want to make them available to the kids the medicine recommended by their doctors to achieve some better quality of life -- some reduction in pain -- that they should have to move," Edwards said.
As detailed in a post below from last year, Louisiana had passed a medical marijuana law in 2015 that required doctor "prescriptions" that made the reform essentially non-functional. This local story indicates the new law takes care of this problem and covers additional ground:
Senate Bill 271 changes the legal wording to allow doctors to recommend nonsmokable forms of medical cannabis to qualified patients.
The new law also expands the state’s list of medical marijuana qualifying conditions to include cancer, glaucoma, HIV, AIDS, cachexia or wasting syndrome, seizure disorders, epilepsy, spasticity, severe muscle spasms, Crohn’s disease, muscular dystrophy and multiple sclerosis.
The previous version of the law included just three qualifying conditions: glaucoma, cancer and spastic quadriplegia.
Prior related post from 2015: Louisiana now with broadest (and least functional?) medical marijuana laws in South
Wednesday, May 18, 2016
As reported in this local article, headlined "Ohio pharmacy board would run medical marijuana program under bill changes," the Ohio legislative process keep moving ahead swiftly as the state continue a path toward becoming the latest to enact significant medical marijuana reforms. Here are the details:
Patients would be allowed to use medical marijuana from other states while Ohio sets up its own program, under changes made to a bill moving quickly through the General Assembly. House Bill 523 would allow people with certain medical conditions to buy and use marijuana with permission of an Ohio-licensed physician. The Senate Government Oversight and Reform Committee on Wednesday made several changes to speed up the time line for establishing the program and increase patient participation in the process.
The biggest change made was moving the medical marijuana program from the Department of Commerce to the state Pharmacy Board. Sen. Dave Burke, a Marysville Republican and pharmacist, said the board would begin licensing cultivators six months earlier than under the previous version of the bill. Then the board would write rules for businesses that make marijuana products and retail dispensaries.
Burke said the bill has no written limit on who can participate; it maintains a requirement that minority business owners receive 15 percent of all marijuana business licenses. "It's not the intent to have a monopoly but to have a market of equity and equal participation," Burke said....
Patients could obtain and use marijuana from other states before it's legally sold in Ohio without being arrested, if it was recommended by a doctor for a qualifying condition and not smoked. Each dispensary would be under the control of a licensed pharmacist.
Doctors would not be required to specify dosage and delivery methods in their recommendations nor submit periodic reports about their recommendations. Recommendations would be good for 90 days and doctors could renew them for three additional periods without seeing the patient....
A 12-member advisory board including a patient, caregiver, nurse, physicians, pharmacists and representatives from law enforcement, labor, and employers. Some members would have to support medical marijuana use.
Alzheimer's disease and fibromyalgia would be added to the list of qualifying medical conditions.
Employers would have to prove employees violated a workplace anti-drug policy for the employee to lose unemployment or workers' compensation benefits, and employees could appeal similar to other controlled substances.
Two problems advocates have with the bill were not changed. Smoking marijuana is not allowed in the bill, but patients could inhale vaporized cannabis. The bill does not allow people to grow their own marijuana.
The bill cleared the Ohio House last week with broad, bipartisan support, and has been fast-tracked for passage before lawmakers break for summer.
Tuesday, May 17, 2016
I am a fairly strong proponent of marijuana reforms in large part because there seem to be a number of tangible immediate benefits from legalizating, regulating and taxing the marijuana marketplace, while significant drawbacks rarely prove to be as dire as predicted by opponents of reform. Two new stories in major newspapers today discussing developments in Colorado reinforce my views. Here are headlines, links and exceepts:
From USA Today here, "These kids are going to college on pot":
Colorado pot smokers are helping send 25 students to college, the first scholarships in the U.S. funded with taxes on legal marijuana. The awards offered by Pueblo County, in southern Colorado, are the latest windfall from legal Colorado marijuana sales that are also helping build schools and aid the homeless — and in one county, providing 8% raises to municipal workers.
Pueblo County is granting $1,000 each to the students, with recipients to be announced later this month. “It’s incredible,” said Beverly Duran, the executive director of the Pueblo Hispanic Education Foundation, which is overseeing the scholarships. "Every year we get a nice pool of students … but we can always only award to a small percentage. This for us expands that to extraordinary lengths.”...
Further south in Colorado, Huerfano County expects to collect an extra $500,000 in cannabis taxes this year. That’s bankrolling an 8% raise for almost all of the county's 96 municipal employees, a big deal in an area where a county road worker earns $12 an hour and most employees haven’t had a raise in more than five years....
In Aurora, the state’s third-largest city, marijuana taxes are helping improve roads, pay off a municipal recreation center, and provide direct services for homeless men and women. Aurora has nearly 20 pot shops and five grow sites, generating a projected $5.4 million in new taxes this year.
From the Los Angeles Times here, "Governor who called legalization 'reckless' now says Colorado's pot industry is working":
“The predictions of fire and brimstone have failed to materialize,” said Mason Tvert, spokesman for the Marijuana Policy Project, a national group working to reform pot laws. “Most Coloradoans, including the governor, recognize that the law is working.”
From the start, [Colorado Gov] Hickenlooper saw the legalization of marijuana as a great national experiment, something utterly new in this country and fraught with potential public health and safety issues. He fretted about a potential rise in drug use among children and was clearly uncomfortable with an amendment directly conflicting with federal law, which considers pot an illegal drug on par with cocaine.
There were plenty of snags at first. Marijuana edibles proved especially problematic because few people had experience with them. High-profile overdoses made national news. Just last week a lawsuit was filed against the maker of a marijuana-laced candy, alleging the product triggered a "psychotic episode" that caused a man to kill his wife in 2014. Still, none of Hickenlooper’s worst fears were realized.
Colorado is booming. The state has a 4.2% unemployment rate, one of the best in the country. High-tech companies are moving in. Small towns across the state, some once teetering on the brink of bankruptcy, have been saved by tax revenues from pot dispensaries. And the $1-billion-a-year cannabis business will pump $100 million in taxes into state coffers this year.
Andrew Freedman, director of marijuana coordination for Colorado, said the governor’s views reflect a growing sense of optimism about how the industry is regulated. “In the short run, there have been a lot fewer public safety and health issues than the governor feared in the beginning,” said Freedman, who is often referred to as the state’s marijuana czar. “In the beginning, we had problems with edibles and hash oil fires but now, for the most part, Colorado looks a lot like it did before legalization.”
Marijuana consumption has not changed much from pre-legalization levels and there has been no significant increase in public health and safety problems, he said. As for the $100 million in tax revenue, Freedman noted, that's out of a $27-billion state budget. Some 70% of the money is earmarked for school construction, public health initiatives and other projects. The rest goes back into regulating the industry.
“The governor has called this a grand experiment from the beginning. He looks at data points as he goes along and I think he’s pleasantly surprised that there were not as many challenges as he thought,” Freedman said. “He would say the jury is still out on this experiment but he’s optimistic.”
Some are less circumspect. “The state’s image is actually rising. We were just ranked as the best place to live in America,” Tvert said. “The idea that businesses would not relocate here or conferences wouldn’t be held here was untrue. In fact, attendees at conferences are now offered pot tours as day trips.”
May 17, 2016 in History of Marijuana Laws in the United States, Recreational Marijuana Commentary and Debate, Recreational Marijuana Data and Research, Recreational Marijuana State Laws and Reforms, Taxation information and issues , Who decides | Permalink | Comments (0)
The title of this post is the headline of this notable new CNN article, which discusses Israel's medical marijuana program. Here are excerpts:
Moments of joy are all too brief for Lavie Parush. They have been since the 2-year-old was born. "Gray" was the word his father used to describe his son, born unconscious. That night, Lavie had his first seizure. "Immediately, they took him to the emergency room," said his father, Asaf Parush. "They doped him up and he was basically passed out the first week of his birth."
For six months, Parush and his wife, Noa, held on to the belief that Lavie's condition would improve. But the seizures worsened. He suffered dozens a day. Doctors diagnosed him with epilepsy and cerebral palsy. Lavie was severely brain damaged.
Doctors put the baby on one drug after another to try to stop the seizures. Each drug required another visit to the hospital. And each one led to another disappointment as the seizures continued unabated. Some drugs had severe side effects, Parush said. Steroids, for example, weakened Lavie's immune system and caused him to become incredibly bloated.
Just before Lavie's first birthday, Parush heard about the use of medical marijuana -- commonly called medical cannabis in Israel -- to treat epilepsy. Unlike other medicines, cannabis is not prescribed by a doctor in Israel. Instead, specialist doctors request a license for a patient to use cannabis for treatment of chronic pain, chemotherapy-induced symptoms, epilepsy and other conditions. The license allows medical cannabis patients between 20 and 200 grams per month. The cannabis is sold at a fixed price of approximately $100 per month, regardless of the amount.
The Ministry of Health points out that the efficacy and safety of medical cannabis "have not yet been established," but the ministry also acknowledges cannabis can help patients suffering from certain medical conditions. Israel has approximately 23,000 licensed medical cannabis users, according to Daniel Goldstein, an industry advocate with Israel Cannabis. Recreational cannabis remains illegal in the country....
Lavie's family requested a license for him from the Ministry of Health for the boy to use medical cannabis. He takes a few drops of cannabis oil every day, mixed into his food. "After a few weeks we didn't see any seizures at all," Parush said.
The cannabis oil, extracted from a strain of cannabis called Avidekel, was developed in northern Israel by one of the country's largest cannabis growers, Tikun Olam. The oil is high in cannabidiol -- or CBD - the pharmacological ingredient in cannabis that has been shown to have anti-inflammatory properties. It is low in tetrahydrocannabinol (THC), the psychoactive ingredient that makes marijuana users high and has been shown to relieve pain.
According to Tikun Olam, Avidekel is the strain used for toddlers and babies. Of Tikun Olam's 6,500 medical cannabis users, only 15 are under 3 years old. The Ministry of Health couldn't confirm the number of toddler and baby cannabis patients in Israel, but Tikun Olam's spokeswoman Ma'ayan Weisberg estimates that no more than 25 children under 3 years old are licensed....
A 2015 study by Dr. Orrin Devinsky of the NYU Langone Comprehensive Epilepsy Center showed a 54% reduction in some types of seizures in 137 people suffering from severe epilepsy who took a liquid form of medical marijuana and did not respond to other treatments. But the study's results will need to be replicated, since it did not adhere to the strictest standards of scientific research, including randomized testing and peer review.
A 2013 Stanford University survey of 19 children between the ages of 2 and 16 suffering from epilepsy found 16 of them self-reported or their parents reported a reduction in seizures from using medical cannabis....
Dr. Uri Kramer, head of the Department for the Treatment of Childhood Epilepsy at Tel Aviv's Ichilov Hospital, said medical cannabis shows promising results in children whose epilepsy has not responded to multiple drugs. "If they are not good candidates for surgery, there are almost no options," said Kramer, who requested the medical cannabis license for Lavie.
Kramer said his patients have shown that medical cannabis has a success rate of approximately 20% in reducing seizures by 75% in epileptic children. "That's much higher than any other drug on the market," said Kramer. But acceptance is not universal. "Some of our colleagues are not convinced yet," he added. "I'd say only about half of the pediatric epiloptologists in Israel are using cannabis."
Research is underway regarding CBD use in children with intractable epilepsy, according to Dr. Angus Wilfong, a pediatric neurologist at Texas Children's Hospital, but Wilfong urged caution. "These studies are complex and take time. No drug should be approved for use in children until scientific studies have validated its efficacy, safety, tolerability, and dosage," said Wilfong.
Monday, May 16, 2016
Active player urges NFL to allow its employees to use medical marijuana rather than opioids for pain relief
Regular readers of this blog likely know that I think pro football players could (and perhaps will) be hugely important social force in charging national perceptions concerning marijuana as a legitimate medicine for dealing with pain. Consequently, I find both notable and significnat this recent New York Times piece headined "Raven Calls on N.F.L. to Allow Marijuana Use for Sport’s Pains." Here are excerpts:
Eugene Monroe has had his share of bumps and bruises during his sevenyear N.F.L. career as an offensive tackle with the Jacksonville Jaguars and the Baltimore Ravens. He has had shoulder injuries, ankle sprains, concussions and all the usual wear and tear that comes from hitting defenders dozens of times a game.
To deal with these injuries, Monroe has stepped forward and called upon the N.F.L. to stop testing players for marijuana so he and other players can take the medical version of the drug to treat their chronic pain, and avoid the addictive opioids that teams regularly dispense. “We now know that these drugs are not as safe as doctors thought, causing higher rates of addiction, causing death all around our country,” Monroe said in an interview on Friday, “and we have cannabis, which is far healthier, far less addictive and, quite frankly, can be better in managing pain.”
Retired football players like Kyle Turley and Ricky Williams have promoted the benefits of marijuana and called for the league to acknowledge those benefits. Monroe, though, may be one of the first to openly urge the league to stop testing for the drug, possibly risking the wrath of owners, league officials and other players.
In a series of posts on Twitter in March, Monroe castigated Commissioner Roger Goodell for refusing to modify the league’s stance on the drug. Monroe also donated $10,000 to help pay for research on the benefits of medical marijuana, and he challenged other players to match his gift. “It’s a shame that Roger Goodell would tell our fans there’s no medical vs recreational distinction,” Monroe wrote.
Last week, Monroe said he had given $80,000 to Realm of Caring, a Colorado-based advocacy group that is working with the Johns Hopkins University School of Medicine to study the impact of medical marijuana on traumatic brain injury and chronic traumatic encephalopathy, a degenerative brain disease linked to repeated hits to the head. Monroe also started a website about the use of marijuana for pain management.
Though two dozen states now allow the use of some forms of marijuana, the N.F.L. has not softened its stance on the drug. Before the Super Bowl in February, Goodell said the league’s medical advisers continued to look at the research but did not have enough evidence to warrant a change in the league’s position. “Yes, I agree there have been changes, but not significant enough changes that our medical personnel have changed their view,” Goodell said. “Until they do, then I don’t expect that we will change our view.”
Even if the N.F.L. changed its position, any changes to the league’s policy on banned substances would have to be negotiated with the N.F.L. Players Association. Monroe said that he had met with the association’s executive director, DeMaurice Smith, and that talks were continuing....
Monroe said that players had told him that they supported his call to soften the league’s stance on marijuana testing, but no current player has publicly backed him. The Ravens’ owner, Steve Bisciotti, tacitly supported Monroe. “We’re not the ones taking that physical abuse,” Bisciotti told balitmoreravens.com. “We’re not talking about a kid that’s been suspended three times coming out and saying that. I respect Eugene a lot, and I think all he asked for is more studying on the subject.”...
Monroe said he was not afraid of any retribution for his stance in part because he said he did not use marijuana. But from the research he has done, Monroe said the benefits were strong enough to justify pushing the league and the union to relax its position, even if it hurt his standing in the N.F.L. “My health is far more important than any possible career implications,” Monroe said. “I want to be there for my family.”
Some prior related posts on NFL players and marijuana use:
Sunday, May 15, 2016
The title of this post is the headline of this notable new Christian Science Monitor article. It carries this subheadline: "A California law passed in October denies felons with drug convictions a license to sell medical marijuana. An new initiative would change that." And here are excerpts:
If you committed a felony for something that is no longer illegal, should your criminal record keep you out of the business now? A California law denying medical marijuana licenses to those with felony convictions for drug possession answers that question with a "yes," and it touches on the debate about how long a felony record should follow someone who has served their time....
The question could have even deeper implications for the state's pot industry, because although only medical marijuana is legal now, California voters will likely see a referendum for full marijuana legalization on the November ballot. Many current or prospective sellers of medical marijuana do have felony charges because of – for example – past drug possession. Casey O'Neill, board chairman of the marijuana group California Growers Association, told the Los Angeles Times' Patrick McGreevy that 25 to 30 percent of California's weed growers have felony convictions.
The current initiative, if passed by referendum in November, would change the law to permit people with felonies for drug possession of any kind to apply for a license to sell marijuana, according to the Coalition for Responsible Drug Policies for California.
Some members of law enforcement suggested that giving felons licenses to sell marijuana supports the growing pot industry at the expense of safety. "This new initiative will specifically allow for convicted major meth and heroin dealers to be licensed recreational marijuana vendors in California," said Chief Ken Corney, president of the California Police Chiefs Association, in a statement. "You have to question proponents in terms of placing personal wealth and corporation profits ahead of community well-being."
California's law enforcement has said fighting the black market by keeping felons out of these businesses is part of the reason the state requires licenses. California Assemblyman Tom Lackey (R) said the October law provides law enforcement with "clear rules for overseeing medical marijuana activities in their community—something badly lacking for the past 20 years," according to a press release for the California Police Chief Association.
Other states where medical marijuana is legal have different approaches to the question of whether a person convicted of selling marijuana before the state legalized it deserves a legal license now. Applicants for a medical marijuana license in Colorado must have all felony charges and sentences at least five years behind them; for drug charges, their record must have been clean for ten years. Colorado offers a case-by-case exemption for past state-level marijuana charges "that would not be a felony if the person were convicted of the offense on the date he or she applied," according to the Colorado Department of Revenue.
May 15, 2016 in Criminal justice developments and reforms, Initiative reforms in states, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Saturday, May 14, 2016
The Tax Foundation describes itself as the "nation’s leading independent tax policy research organization," and it claims that "since 1937, [its] principled research, insightful analysis, and engaged experts have informed smarter tax policy at the federal, state, and local levels." Helpfully, it has recently turned its attention to marijuana reform via these two new publications:
Here are the "Key Findings" from these two reader-friendly reports (which overlap a bit):
- Marijuana tax collections in Colorado and Washington have exceeded initial estimates.
- A mature marijuana industry could generate up to $28 billion in tax revenues for federal, state, and local governments, including $7 billion in federal revenue: $5.5 billion from business taxes and $1.5 billion from income and payroll taxes.
- A federal tax of $23 per pound of product, similar to the federal tax on tobacco, could generate $500 million per year. Alternatively, a 10 percent sales surtax could generate $5.3 billion per year, with higher tax rates collecting proportionately more.
- The reduction of societal risk in being engaged in the marijuana trade, as well as the inclusion of taxes, will combine to reduce profits (and tax collections) somewhat from an initial level after national legalization.
- Society pays all the costs regardless of legality but tax revenues help offset those costs.
- Marijuana tax collections in Colorado and Washington have exceeded initial estimates, and a nationwide legalization-and-tax regime could see states raise billions of dollars per year in marijuana tax revenue.
- Colorado, Washington, and Oregon have all taken steps to reduce their marijuana tax rates, with Alaska considering it, after initial rates of 30 percent or more did not reduce the black market sufficiently. More recent ballot initiative proposals across the country propose rates between 10 and 25 percent.
- Tax rates on final retail sales have proven the most workable form of taxation. Other forms of taxation that have been proposed, such as taxing marijuana flowers at a certain dollar amount, taxing at the processor or producer level rather than the retail level, or taxing products by their level of THC, have faced practical implementation difficulties.
- Medical marijuana is usually more loosely regulated and less taxed than recreational marijuana. In Washington, moving non-medical sales to the retail market has proven difficult given the enormous differentials in tax rates and regulatory structure, and officials there wish the two systems had been tackled simultaneously.
- While the revenue can be in the tens or even hundreds of millions of dollars, it takes a lead time to develop. Revenues started out slowly in Colorado and Washington, as consumers became familiar with the new system and after state and local authorities spent time and money setting up new frameworks and regulatory infrastructure.
- Significant attention must be given to health, agricultural, zoning, local enforcement, and criminal penalty issues. These important issues have generally been unaddressed in ballot initiatives and left for resolution in the implementation process.
May 14, 2016 in Business laws and regulatory issues, Medical Marijuana State Laws and Reforms, Recreational Marijuana State Laws and Reforms, Taxation information and issues | Permalink | Comments (0)
This new New York Times article, headlined "How Much Is Too Much Marijuana to Drive? Lawmakers Wonder," not only picks up on the recent AAA reports on marijuana impairment and driving, but also spotlights how federal law continues to get in the way of needed research on these issues:
As more states consider legalizing the substance, that presents a challenge to legislators seeking to create laws on driving while impaired by marijuana.
The study, commissioned by the AAA Foundation for Traffic Safety, found that laws in six states that legally assess impairment by measuring how much THC (the active ingredient in marijuana) is in a person’s blood are not supported by science. “There is no concentration of the drug that allows us to reliably predict that someone is impaired behind the wheel in the way that we can with alcohol,” said Jake Nelson, AAA’s director of traffic safety advocacy and research....
The AAA study echoes the recommendations of many experts who call for the improvement of technology to evaluate drivers’ saliva for cannabis use.
Sean O’Connor, the faculty director of the Cannabis Law and Policy Project at the University of Washington, said that there was promising research into detecting cannabis through saliva and other techniques, but that it was being stymied by the drug’s legal classification as a Schedule 1 substance. “We are hamstrung by the fact that you can’t do legitimate scientific research unless you have a Schedule 1 license,” he said. His argument underlines the difficulty for states trying to write coherent policy when the drug is still illegal under federal law.
Prior recent related post:
Friday, May 13, 2016
Earlier this week, I had the great honor and pleasure of talking with Jeffrey Rosen and Randy Barnett as part of the National Constitution Center's "We the People" series concerning various constitutional issues related to the regulation and legalization of marijuana. The podcast is available at this link, and here is how it is introduced via that webpage:
Marijuana was first outlawed nationally by the Marijuana Tax Act in 1937. Since 1970, it has been classified an illegal Schedule 1 drug under the Controlled Substances Act, listed alongside LSD, heroin, and other narcotics.
But in 1996, California became the first state to allow the use of marijuana for medical purposes, starting a cascade of changes at the state level. As of May 2016, 24 states and D.C. have legalized medical marijuana; four states — Colorado, Washington, Oregon, Alaska—and D.C. have also legalized recreational marijuana. In November 2016, more states, including Nevada and Maine, are slated to vote on the issue.
Join We the People to explore the constitutional issues at stake....
May 13, 2016 in Federal Marijuana Laws, Policies and Practices, History of Marijuana Laws in the United States, Medical Marijuana Commentary and Debate, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Thursday, May 12, 2016
Marijuana sales and tax revenues keep going up and up in Colorado ... while tangible new serious problems seem still not to have (yet?) materialized
This new Denver Post piece, headlined "Colorado pot shops have already sold $270 million of marijuana in 2016," reports that "in the first three months of 2016, Colorado's pot shops sold more than $270 million of marijuana and related products." Here is more:
The state’s latest data shows that its marijuana shops sold nearly $90 million of cannabis in March 2016. The licensed stores sold more than $55 million in recreational marijuana and more than $33 million in medical cannabis in March, the latest month for which the department has released tax data for the industry. Totals for retail and medical marijuana dipped slightly in March after a bustling February, which was the state’s fifth most lucrative month for sales since they began in January 2014, according to Cannabist calculations and state data.
March 2016 totals for recreational pot sales are up 30 percent from March 2015, which shows that “marijuana sales remain strong,” said Christian Sederberg, an attorney for the cannabis industry. “As the regulated system continues to work, we’re also on pace to have over $40 million in excise taxes, meaning there could be additional taxes available from the excise tax to be used for something beyond the public school construction fund.”
Among the taxes collected on retail pot sales is the school-funding 15 percent excise tax on wholesale marijuana transfers, which amounted to $3.5 million in March. One of the cornerstones of the campaign that successfully ran Colorado’s pot-legalizing Amendment 64 says that the first $40 million raised by that excise tax will go toward school construction projects. That specific tax totaled $13.3 million in 2014 and $35 million in 2015, and industry analysts — Sederberg included — say they are confident it will top $40 million in 2016.
Colorado marijuana outlets sold more than $699 million of product in 2014 and more than $996 million in 2015. Year-over-year totals for taxes and license fees grew too, from $76 million in 2014 to $135 million in 2015. There are three types of state taxes on recreational marijuana: the standard 2.9 percent sales tax; a 10 percent special marijuana sales tax; and a 15 percent excise tax on wholesale marijuana transfers. For March, Colorado collected more than $11.3 million in recreational taxes and fees and more than $1.7 million in medical taxes and fees.
Intriguingly, this notable new Atlantic piece, headlined "The Failed Promise of Legal Pot: New laws on marijuana were supposed to boost tax revenues and free up cops to go after “real” criminals. But underground sales — and arrests — are still thriving," details that marijuana legalization in Colorado and other states has not yet completely eliminated the historic black-market realities of marijuana distribution. Though I find useful this article's reminder that, even after legalization, there can be many persistent black market and prohibition problems, I also think the article highights reasons why we may expect marijuana sales and tax revenues to keep on increasing over time as more and more local marijuana consumers come to prefer engaging with the newer-and-always-innovating legal market over their older-and-surely-less-dynamic black market.
In addition to noting these sales and tax revenue trends, the headline of my post here is meant to flag the reality that we do not seem to have yet seen evidence of increasing serious new problems in Colorado to parallel the evidence of increasing sales and tax revenue. If there were significant tangible short-terms harms that follow directly from legalizing recreational marijuana and having robust retail sales, I think those harm would now start to become very obvious now nearly 45 months since Colorado voters enacted full legalization and 30 months into having retail outlets selling lots of this product. Moreover, if there were significant tangible short-terms harms that follow directly from legalizing recreational marijuana, not only should they be evident by now, but they should be contining to grow and become even more evidence as legal sales continue to increase.
Critically, it is certainly possible that there are significant long-term harms for Colorado and elsewhere that can be linked directly to marijuana legalization and increasing legal sales, especially with respect to health concerns. (The parallel here to tobacco should be clear: having lots of people smoke lots of cigarettes does not produce a lot of obvious short-term harms, but the long-term harms we now know are quite significant.) But if sales and tax revenues keep going up and evidence of major problems are not yet materializing, it is going to be difficult to effectively campaign in other states against marijuana reform when the tangible cost-benefit realities in Colorado so far seem pretty darn good.
May 12, 2016 in History of Marijuana Laws in the United States, Recreational Marijuana Data and Research, Recreational Marijuana State Laws and Reforms, Taxation information and issues | Permalink | Comments (0)
Wednesday, May 11, 2016
The title of this post is the headline of this BuzzFeed report. Here are excerpts:
Black and Latino adolescents in Colorado are being arrested for marijuana offenses at more disproportionate rates than they were before the state legalized recreational use of the drug, according to a new report from the Colorado Department of Public Safety.
The report, released in March, found a striking racial disparity in how adolescents aged 10–17 are being arrested: White juvenile marijuana arrests decreased by 8% between 2012 and 2014, while black juvenile arrests increased by 58% and Latino juvenile arrests increased 29%.
Colorado voters passed an initiative legalizing recreational marijuana use in 2012 — the year is used in the report to represent pre-legalization. The first full year that the state’s 21-and-older recreational marijuana market was operational was 2014.
Between 2012 and 2014, Colorado elementary and secondary schools saw a 34% increase in marijuana arrests, the overwhelming majority of which were for possession. These arrests were often done by “school resource officers” — local police officers who have increasingly been stationed on campuses in recent years. Although most of these juvenile arrests do not involve jail time, the student must pay a fine and, in order to get the arrest expunged from their permanent record, pay to participate in a drug education class....
According to a 2013 survey done by the Colorado Department of Public Health and Environment, Pueblo County has the highest rates of teen marijuana use in the state — 32.1% of high schoolers — but only five adolescents were arrested for marijuana-related crimes there in 2014. Compare that to Arapahoe County, which has about average rates of teen marijuana use (20.6% of high schoolers) when compared to the rest of the state (19.7%), but where nearly 400 students were arrested for marijuana in 2014.
Tustin Amole, the director of communications at Cherry Creek Schools in Arapahoe County, said that while her district decides how to handle marijuana offenses on a case-by-case basis, she felt the students who are being arrested accurately reflect which students are smoking pot. “We don’t really have zero tolerance policies, because there are so many variations and circumstances. You have to take them all into account,” Amole told BuzzFeed News. “All I can say is while it may seem disproportionate, those are the students we’re catching with the drugs.”
The state also found that while marijuana arrests among adults have nearly been cut in half since legalization, the racial disparities among those still being arrested grew slightly worse. In 2014, black people were arrested and cited for marijuana-related offenses at almost triple the rate of white people. Back in 2012, black people in Colorado were being arrested for pot crimes at a little less than double the rate of whites.
While national data has shown that adults and juveniles of all races use and sell marijuana at very similar rates, the 2013 survey done by the Colorado Department of Public Health and Environment found that a slightly bigger percentage of black (25.9%) and Latino (23.6%) high schoolers had used marijuana in the past 30 days, compared to white students (17%). But even if the disparity in that sample was representative for the entire state, the marijuana arrest numbers for black juveniles would still be wildly disproportionate. Other states and cities that have decriminalized or legalized recreational marijuana use — including Massachusetts, Chicago, and Washington state — have seen a similar trend: a drop in overall arrests but persistent or increased racial disparities among those still being arrested.